Filing Details

Accession Number:
0001140361-15-019186
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-12 18:41:28
Reporting Period:
2015-05-08
Filing Date:
2015-05-12
Accepted Time:
2015-05-12 18:41:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293818 Opgen Inc OPGN,OPGNW Services-Medical Laboratories (8071) 061614015
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
893739 Harris & Harris Group Inc /Ny/ 1450 Broadway
24Th Floor
New York NY 10018
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-08 300,833 $6.00 330,716 No 4 P Direct
Common Stock Acquisiton 2015-05-08 610,017 $0.00 940,733 No 4 C Direct
Common Stock Acquisiton 2015-05-08 209,020 $0.00 1,149,753 No 4 C Direct
Common Stock Acquisiton 2015-05-08 260,043 $0.00 1,409,796 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Redeemable Convertible Preferred Stock Disposition 2015-05-08 610,017 $0.00 610,017 $0.00
Common Stock 2014 Convertible Notes Disposition 2015-05-08 209,020 $0.00 209,020 $0.00
Common Stock 2015 Convertible Notes Disposition 2015-05-08 260,043 $0.00 260,043 $0.00
Common Stock Warrants Acquisiton 2015-05-08 300,833 $0.00 300,833 $6.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
300,833 2015-05-08 2020-05-08 No 4 P Direct
Footnotes
  1. Series A Redeemable Convertible Preferred Stock automatically converted into common stock on a 1-to-1 basis upon the consummation of the Company's initial public offering.
  2. The 2014 Convertible Notes automatically converted into shares of Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of one share of Series A Preferred Stock for every $1.00 of principal converted. Each share of Series A Preferred Stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
  3. The 2015 Convertible Notes converted into Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of 1.25 shares of Series A Preferred Stock for each $1.00 of principal converted. Each share of Series A Preferred stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.